Related Experiment Video
Updated: Oct 20, 2025

Primordial Germ Cell Transplantation for CRISPR/Cas9-based Leapfrogging in Xenopus
Published on: February 1, 2018
Modeling Human Genetic Disorders with CRISPR Technologies in Xenopus
Helen Rankin Willsey1, Matthew Guille2, Robert M Grainger3
1Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94143, USA; helen.willsey@ucsf.edu rmg9p@virginia.edu.
This study presents a pipeline combining Xenopus developmental biology and CRISPR technology to understand human genetic disorders. It enables functional insights into disease-related genes for potential therapeutic development.
Area of Science:
- Developmental biology
- Genetics
- Biotechnology
Background:
- Human genetic disorders pose significant health challenges.
- Understanding gene function is crucial for disease etiology.
- Xenopus laevis offers a powerful model for studying gene function.
Purpose of the Study:
- To provide a practical pipeline for investigating disease and risk genes.
- To gain functional insights into gene contributions to human disorder etiology.
- To leverage Xenopus developmental biology and CRISPR technologies for genetic research.
Main Methods:
- Utilizing Xenopus as a model organism.
- Employing CRISPR-based gene editing technologies.
- Developing a pipeline from gene identification to functional analysis.
Main Results:
- A practical pipeline is established for disease gene research.
- Functional insights into gene contributions to human disorders can be obtained.
- The integration of Xenopus and CRISPR accelerates discovery.
Conclusions:
- Combining Xenopus developmental biology with CRISPR technology accelerates understanding of human genetic disorders.
- This pipeline facilitates functional gene analysis for disease research.
- The approach holds promise for developing new treatments for genetic conditions.
More Related Videos
Related Concept Videos
CRISPR
What is Genetic Engineering?
CRISPR/Cas9 Genome Editing

